Making Accelerated Predictive Stability Studies Even Faster With Software

By Sarah Srokosz, Marketing Communications Specialist, ACD/Labs

Drug stability is a critical yet complex challenge, shaped by environmental factors such as temperature, humidity, and light. As molecules degrade, patients may face reduced efficacy or unexpected side effects—making accurate stability assessment essential from the earliest stages of development. Traditional experimental methods, while reliable, are often too slow and resource-intensive to guide early decisions. Accelerated predictive stability (APS) offers a powerful alternative, applying mathematical modeling to simulate chemical degradation and forecast performance across conditions. By combining scientific rigor with computational efficiency, APS enables faster insights, better-informed formulation strategies, and more confident progression through development.

Find out how predictive modeling is reshaping stability studies and unlocking new efficiencies across the pharmaceutical pipeline.